Davis Polk advised the joint book-running managers in connection with a $2.25 billion registered offering by Eli Lilly and Company of $750 million principal amount of its 2.350% notes due 2022, $750 million principal amount of its 3.100% notes due 2027 and $750 million principal amount of its 3.950% notes due 2047.

Headquartered in Indianapolis, Indiana, Eli Lilly discovers, develops, manufactures and markets products in two business segments — human pharmaceutical products and animal health products. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico and 14 other countries. Eli Lilly products are sold in approximately 125 countries.

The Davis Polk corporate team included partners Richard A. Drucker and John G. Crowley and associates Ferrell Maguire Keel and Marcus Tan. The tax team included partner Michael Mollerus and associate Kelli A. Rivers. The environmental team included counsel Loyti Cheng. The intellectual property and technology team included counsel David R. Bauer. Members of the Davis Polk team are based in the New York and London offices. 

Copy link to share post